| Literature DB >> 26905739 |
Zixin Wang1,2, Tiejian Feng3, Joseph T F Lau1,2,4, Yoona Kim1.
Abstract
Voluntary Medical Male circumcision (VMMC) is an evidence-based, yet under-utilized biomedical HIV intervention in China. No study has investigated acceptability of VMMC among male sexually transmitted diseases patients (MSTDP) who are at high risk of HIV transmission. A cross-sectional survey interviewed 350 HIV negative heterosexual MSTDP in Shenzhen, China; 12.0% (n = 42) of them were circumcised at the time of survey. When the uncircumcised participants (n = 308) were informed that VMMC could reduce the risk of HIV infection via heterosexual intercourse by 50%, the prevalence of acceptability of VMMC in the next six months was 46.1%. Adjusted for significant background variables, significant factors of acceptability of VMMC included: 1) emotional variables: the Emotional Representation Subscale (adjusted odds ratios, AOR = 1.13, 95%CI: 1.06-1.18), 2) cognitive variables derived from Health Belief Model (HBM): perceived some chance of having sex with HIV positive women in the next 12 months (AOR = 2.48, 95%CI: 1.15-5.33) (perceived susceptibility), perceived severity of STD infection (AOR = 1.06, 95%CI: 1.02-1.10), perceived benefit of VMMC in risk reduction (AOR = 1.29, 95%CI: 1.16-1.42) and sexual performance (AOR = 1.45, 95%CI: 1.26-1.71), perceived barriers against taking up VMMC (AOR = 0.88, 95%CI: 0.81-0.95), and perceived cue to action (AOR = 1.41, 95%CI: 1.23-1.61) and self-efficacy (AOR = 1.38, 95%CI: 1.26-1.35) related to taking up VMMC. The association between perceived severity of STD infection and acceptability was fully mediated by emotional representation of STD infection. The relatively low prevalence of circumcision and high acceptability suggested that the situation was favorable for implementing VMMC as a means of HIV intervention among MSTDP in China. HBM is a potential suitable framework to guide the design of future VMMC promotion. Future implementation programs should be conducted in STD clinic settings, taking the important findings of this study into account.Entities:
Mesh:
Year: 2016 PMID: 26905739 PMCID: PMC4764373 DOI: 10.1371/journal.pone.0149801
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Background characteristics of the respondents.
| All (n = 350)% | Uncircumcised (n = 308) % | Circumcised (n = 42) % | P value | |
|---|---|---|---|---|
| Age group | ||||
| 18–30 | 37.7 | 37.7 | 38.1 | |
| 31–40 | 36.9 | 37.3 | 33.3 | |
| 41–50 | 18.9 | 18.2 | 23.8 | |
| >50 | 6.6 | 6.8 | 4.8 | 0.796 |
| Current marital status | ||||
| Single | 28.3 | 29.2 | 21.4 | |
| Married or cohabited with a woman | 66.9 | 65.6 | 76.2 | |
| Divorced, separated or widowed | 4.9 | 5.2 | 2.4 | 0.365 |
| City of permanent residence (Hukou) | ||||
| Shenzhen | 29.1 | 28.9 | 31.0 | |
| Other city in Guangdong | 21.7 | 22.4 | 16.7 | |
| Other province in China | 49.1 | 48.7 | 52.4 | 0.699 |
| Highest education level attained | ||||
| Junior high or lower | 32.3 | 33.1 | 26.2 | |
| Senior high school (or equal academic qualification) | 27.1 | 26.9 | 28.6 | |
| College | 19.7 | 18.5 | 28.6 | |
| University or above | 20.9 | 21.4 | 16.7 | 0.410 |
| Monthly personal income (RMB) | ||||
| <3,000 | 22.9 | 23.1 | 21.4 | |
| 3,000–4,999 | 28.9 | 28.9 | 28.6 | |
| 5,000–9,999 | 18.9 | 18.5 | 21.4 | |
| ≥ 10,000 | 29.4 | 29.5 | 28.6 | 0.974 |
| People with HIV positive can look healthy | 56.9 | 56.5 | 59.5 | 0.710 |
| HIV antibody cannot be detected one week after HIV transmission | 25.4 | 24.7 | 31.0 | 0.381 |
| People can contract the same STD more than once | 56.9 | 55.2 | 69.0 | 0.089 |
| STD infection will increase the risk of contracting HIV | 40.3 | 39.6 | 45.2 | 0.485 |
| Number of correct responses | ||||
| 0 | 25.7 | 27.6 | 11.9 | |
| 1–2 | 39.7 | 38.4 | 50.0 | |
| 3–4 | 34.6 | 34.0 | 38.1 | 0.083 |
| HIV antibody testing | 37.7 | 37.3 | 40.5 | 0.694 |
| Condom distribution | 12.3 | 12.7 | 9.5 | 0.561 |
| Peer education | 8.3 | 8.1 | 9.5 | 0.756 |
| Lecture on HIV/STD knowledge | 7.7 | 8.1 | 4.8 | 0.445 |
| HIV/STD pamphlet | 24.6 | 25.6 | 16.7 | 0.205 |
| Glans completely exposing in the absence of erection | --- | 18.2 | --- | --- |
| Foreskin partially covered glans in the absence of erection | --- | 43.5 | --- | --- |
| Foreskin completely covered glans in the absence of erection, but can be retracted properly (overly long foreskin) | --- | 38.3 | --- | --- |
| Current STD infection | ||||
| Primary syphilis | 3.4 | 3.6 | 2.4 | |
| Secondary syphilis | 2.6 | 2.6 | 2.4 | |
| Latent syphilis | 17.1 | 17.5 | 14.3 | |
| Genital warts | 40.9 | 39.0 | 54.8 | |
| Genital herpes | 15.7 | 16.2 | 11.9 | |
| Gonorrhea or NGU | 20.3 | 21.1 | 14.3 | 0.559 |
| Episodes of STD infection in previous 3 years | ||||
| 1 | 73.7 | 73.1 | 78.6 | |
| 2 | 17.7 | 18.5 | 11.9 | |
| ≥3 | 8.6 | 8.4 | 9.5 | 0.573 |
| Number of Regular female sex partners (RP) with sexual intercourse | ||||
| 0 | 20.3 | 21.4 | 11.9 | |
| 1 | 76.6 | 75.6 | 83.3 | |
| ≥2 | 3.1 | 2.9 | 4.8 | 0.311 |
| Number of non-regular female sex partners (NRP) with sexual intercourse | ||||
| 0 | 62.0 | 61.0 | 69.0 | |
| 1 | 22.3 | 22.4 | 21.4 | |
| ≥2 | 15.7 | 16.6 | 9.5 | 0.458 |
| Had patronized FSW | ||||
| No | 57.1 | 57.1 | 57.1 | |
| Yes | 42.9 | 42.9 | 42.9 | 1.000 |
| Had had unprotected sex with RP | ||||
| No/had not had sex with RP | 76.0 | 75.6 | 78.6 | |
| Yes | 24.0 | 24.4 | 21.4 | 0.667 |
| Had had unprotected sex with NRP | ||||
| No/had not had sex with NRP | 91.1 | 90.6 | 95.2 | |
| Yes | 8.9 | 9.4 | 4.8 | 0.319 |
| Had had unprotected sex with FSW | ||||
| No/had not had sex with FSW | 92.0 | 91.9 | 92.9 | |
| Yes | 8.0 | 8.1 | 7.1 | 0.827 |
Regular female sex partner(s) (RP): wife or girlfriend
Female sex worker (FSW): female who exchanged sex for money.
Non-regular female sex partner(s) (NRP): female who were neither RP (wife or girlfriend) nor FSW.
Frequency distribution of cognitive variables derived from HBM and emotional representation of STD infection among uncircumcised male STD patients (n = 308).
| % / Mean (SD) | |
|---|---|
| I get depressed when I think about my STD | 63.0 |
| When I think about my STD, I get upset | 65.9 |
| My STD makes me feel angry | 47.1 |
| My STD does not worry me | 36.4 |
| Having this STD make me feel anxious | 60.1 |
| My STD makes me feel afraid | 59.1 |
| Scale Score | |
| Emotional Representation Subscale | 19.5 (5.2) |
| Do you perceive some chance of having sex with HIV positive women in the next twelve months | |
| No | 86.4 |
| Yes | 13.6 |
| Perceived severity of HIV infection (% Severe/very severe) | |
| Harm of HIV infection on physical Health | 92.5 |
| Harm of HIV infection on mental health | 92.5 |
| Harm of HIV infection on work | 84.7 |
| Harm of HIV infection on personal economic status | 85.1 |
| Harm of HIV infection on family relationships | 90.6 |
| Harm of HIV infection on social life | 87.7 |
| Scale Score | |
| HIV Perceived Severity Scale | 26.8 (5.1) |
| Perceived severity of STD infection (% Severe/very severe) | |
| Harm of STD infection on physical Health | 44.8 |
| Harm of STD infection on mental health | 52.9 |
| Harm of STD infection on work | 26.3 |
| Harm of STD infection on personal economic status | 27.9 |
| Harm of STD infection on family relationships | 27.3 |
| Harm of STD infection on social life | 21.8 |
| Scale Score | |
| STD Perceived Severity Scale | 15.3 (6.5) |
| Perceived risk reduction due to VMMC (% strongly agree/agree) | |
| VMMC could reduce the risk of HIV infection | 29.5 |
| VMMC could reduce the risk of STD infection | 34.4 |
| VMMC could reduce female sex partner’s risk of gynecological diseases | 48.1 |
| VMMC could reduce female sex partner’s risk of STD infection | 46.8 |
| Scale Score | |
| Perceived Risk Reduction Scale | 12.8 (2.8) |
| Perceived benefit for sexual performance (% strongly agree/agree) | |
| VMMC would increase sexual pleasure | 22.4 |
| VMMC would increase erectile duration | 49.7 |
| VMMC would increase female sexual partner’s sexual pleasure | 19.2 |
| Scale Score | |
| Sexual Performance Scale | 9.1 (1.9) |
| VMMC is expensive for me | 9.7 |
| VMMC would cause pain on penis | 35.1 |
| VMMC would result in severe surgical complications (e.g. bleeding, edema and inflammation) | 32.1 |
| VMMC would result in erectile dysfunction | 26.9 |
| My peers would consider it strange for me to take up VMMC | 13.0 |
| My female sex partners would consider it strange for me to take up VMMC | 10.8 |
| I am embarrassed to take up VMMC | 20.7 |
| Scale Score | |
| Perceived Barrier Scale | 18.5 (3.3) |
| Some doctors suggested that I should take up VMMC | 28.2 |
| Some of my peers suggested that I should take up VMMC | 11.4 |
| My female sex partner suggested that I should take up VMMC | 9.7 |
| Scale Score | |
| Cue to Action Scale | 9.1 (2.6) |
| I am confident that I can take up VMMC if desired | 60.1 |
| I am confident that I can take up VMMC in the next six months | 31.2 |
| Whether to take up VMMC or not is completely under my control | 31.1 |
| I have sufficient resources enabling me to take up VMMC in the next six months | 33.8 |
| Scale Score | |
| Self-efficacy Scale | 12.6 (3.4) |
Association between background factors and acceptability of VMMC after having been informed that it could reduce risk of HIV infection.
| Row% | ORu (95%CI) | ORm (95%CI) | |
|---|---|---|---|
| Age group | |||
| 18–40 | 50.6 | 1.0 | 1.0 |
| >40 | 32.5 | ||
| City of permanent residence (Hukou) | |||
| Shenzhen | 53.9 | 1.0 | |
| Other cities in China | 42.9 | 0.64 (0.39–1.05) | NS |
| Number of correct responses | |||
| 0 | 29.4 | 1.0 | 1.0 |
| 1–2 | 48.3 | ||
| 3–4 | 57.1 | ||
| HIV antibody testing (last year) | |||
| No | 42.5 | 1.0 | |
| Yes | 52.2 | 1.47 (0.93–2.34) | NS |
| Condom distribution (last 6 months) | |||
| No | 43.5 | 1.0 | |
| Yes | 64.1 | NS | |
| Peer education (last 6 months) | |||
| No | 44.5 | 1.0 | |
| Yes | 64.0 | 2.22 (0.95–5.18) | NS |
| Glans completely exposing in the absence of erection | 35.7 | 1.0 | 1.0 |
| Foreskin partially covering glans in the absence of erection | 36.6 | 1.04 (0.54–1.99) | 1.07 (0.54–2.13) |
| Foreskin completely covering glans in the absence of erection, but can be retracted properly (Overly long foreskin) | 61.9 | ||
| Episodes of STD infection in last 3 years | |||
| 1 | 40.0 | 1.0 | 1.0 |
| 2 | 56.1 | 1.82 (0.99–3.57) | |
| ≥3 | 76.9 | ||
| Number of non-regular female sex partners (NRP) with sexual intercourse | |||
| 0 | 41.0 | 1.0 | |
| 1 | 46.4 | 1.25 (0.72–2.17) | |
| ≥2 | 64.7 | NS |
ORu: univariate odds ratios; ORm: multivariate odds ratios obtained from stepwise logistic regression using background variables P<0.10 in univariate analysis as candidates (entry: P<0.10; exclude: P>0.20) NS: P>0.10; --: univariately non-significant not considered in the model
† P<0.10
* P<0.05
** P<0.01
*** P<0.001
1 Number of correct responses to four HIV/STD related knowledge items: 1) People with HIV positive can look healthy; 2) HIV antibody cannot be detected 1 week after HIV transmission; 3) People can contract same STD more than once and 4) STD infection will increase the risk of contracting HIV.
Associations between HBM-related variables, emotional representation of STD infection and acceptability of VMMC after having been informed that it could reduce risk of HIV infection.
| ORu (95%CI) | AOR (95%CI) | |
|---|---|---|
| Emotional Representation Subscale | ||
| Perceived susceptibility | ||
| Do you perceive some chance of having sex with HIV positive women in the next twelve months | ||
| No | 1.0 | 1.0 |
| Yes | ||
| Perceived severity | ||
| STD Perceived Severity Scale | ||
| Perceived benefit of VMMC | ||
| Perceived Risk Reduction Scale | ||
| Sexual Performance Scale | ||
| Perceived barriers against taking up VMMC | ||
| Perceived Barrier Scale | ||
| Cue to action for VMMC uptake | ||
| Cue to Action Scale | ||
| Self-efficacy for VMMC uptake | ||
| Self-efficacy Scale |
* P<0.05
** P<0.01
*** P<0.001
ORu: univariate odds ratio; AOR: adjusted odds ratio, odds ratios adjusted by multivariately significant background variables (listed in Table 1)
Testing for independent effect of cognitive variables and emotional representation of STD infection on the associations with acceptability of VMMC after having been informed that it could reduce risk of HIV infection.
| Model | Variables | B | S.E. | Adjusted OR (95%CI) | P value |
|---|---|---|---|---|---|
| 1 | Emotional Representation Subscale | 0.102 | 0.030 | ||
| STD Perceived Severity Scale | 0.023 | 0.024 | 1.02 (0.98–1.07) | 0.340 | |
| 2 | Emotional Representation Scale | 0.101 | 0.029 | ||
| Perceived Risk Reduction Scale | 0.230 | 0.052 | |||
| 3 | Emotional Representation Scale | 0.109 | 0.029 | ||
| Cue to Action Scale | 0.326 | 0.068 | |||
| 4 | Emotional Representation Scale | 0.097 | 0.030 | ||
| Self-efficacy Scale | 0.311 | 0.049 |
1Adjusted logistic regression: the analysis adjusted for the multivariately significant background variable (listed in Table 3)